Morphochem Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
90
- Latest Deal Type
-
M&A
Morphochem General Information
Description
Provider of biotechnology research and development services. The company specializes in high speed parallel synthesis of new chemical entities and discovery of drug candidates.
Contact Information
Website
www.morphochem.deCorporate Office
- Gmunder Straße 37a
- 81379 Munich
- Germany
Corporate Office
- Gmunder Straße 37a
- 81379 Munich
- Germany
Morphochem Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 01-Dec-2005 | Completed | Profitable | |||
| 7. Later Stage VC | 06-May-2004 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 01-Aug-2001 | Completed | Startup | |||
| 5. Early Stage VC | 01-Jul-2000 | Completed | Startup | |||
| 4. Early Stage VC | Completed | Startup | ||||
| 3. Early Stage VC | 01-Sep-1999 | Completed | Startup | |||
| 2. Grant | 01-Jan-1998 | $3.57M | $2.23M | Completed | Startup | |
| 1. Early Stage VC | 01-Jan-1998 | $2.23M | $2.23M | Completed | Startup |
Morphochem Comparisons
Industry
Financing
Details
Morphochem Competitors (20)
One of Morphochem’s 20 competitors is Synlogic, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synlogic | Formerly VC-backed | Cambridge, MA | ||||
| Greiner Bio-One International | Corporation | Kremsmünster, Austria | ||||
| Vir | Formerly VC-backed | San Francisco, CA | ||||
| Anoixis | Corporation | Natick, MA | ||||
| Angle (United Kingdom) | Corporation | Guildford, United Kingdom |
Morphochem Patents
Morphochem Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-6589773-B1 | Hexose transporter genes (hxt); pleiotropic drug resistance genes (pdr); gene expression; genetic engineering; promoters; use in high-throughput screening of compounds that modulate macromolecular interactions | Inactive | 17-Feb-2000 | ||
| US-20030003449-A1 | Detection of regulatory element associated wit h protein binding; obtain cell, expression vector, monitor and measure reporter gene expression in the presence and absence of regulatory element | Inactive | 23-Jul-1998 | ||
| US-6174678-B1 | Screening for bactericides that interact with enzymatic polypeptides; providing bacterial testing strains that are isogenic, incubating modulator, detecting sensitivity of bacteria to modulators | Inactive | 03-Nov-1997 | ||
| US-6265174-B1 | Fusion protein associated with regulation of gene expression; for the utilization in detection of modulators of gene expression | Inactive | 03-Nov-1997 | C07K14/245 |
Morphochem Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Morphochem Former Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Berkeley | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| Excalibur Group Holdings | Venture Capital | Minority |
Morphochem Acquisitions (2)
Morphochem’s most recent deal was a Merger/Acquisition with Small Molecule Therapeutics. The deal was made on 20-Mar-2000.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Small Molecule Therapeutics | 20-Mar-2000 | Merger/Acquisition | Biotechnology | ||
| Origenis | Merger/Acquisition | Drug Discovery |
Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Small Molecule Therapeutics | Princeton, NJ | 1997 |
Morphochem FAQs
-
When was Morphochem founded?
Morphochem was founded in 1996.
-
Where is Morphochem headquartered?
Morphochem is headquartered in Munich, Germany.
-
What is the size of Morphochem?
Morphochem has 90 total employees.
-
What industry is Morphochem in?
Morphochem’s primary industry is Biotechnology.
-
Is Morphochem a private or public company?
Morphochem is a Private company.
-
What is Morphochem’s current revenue?
The current revenue for Morphochem is .
-
How much funding has Morphochem raised over time?
Morphochem has raised $91.2M.
-
Who are Morphochem’s investors?
Alta Berkeley, Alta Partners, Domain Associates, EQT Life Sciences, and Excalibur Group Holdings are 5 of 15 investors who have invested in Morphochem.
-
Who are Morphochem’s competitors?
Synlogic, Greiner Bio-One International, Vir, Anoixis, and Angle (United Kingdom) are some of the 20 competitors of Morphochem.
-
When was Morphochem acquired?
Morphochem was acquired on 01-Dec-2005.
-
Who acquired Morphochem?
Morphochem was acquired by Biovertis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
